1/49
A comprehensive vocabulary collection reviewing cancer terminology, classification, tumour pathology, clinical exercise oncology roles across the cancer care continuum, and Australian private health insurance regulations for exercise physiology services.
Cancer
A group of diseases characterized by the uncontrolled division of abnormal cells that bypass apoptosis, invade surrounding tissues, and can spread to distant anatomical sites.
Oncology
The branch of medicine that specializes in the prevention, diagnosis, treatment, and clinical management of cancer.
Medical Oncologist
A specialist physician who treats cancer using systemic pharmaceutical therapies, including chemotherapy, immunotherapy, and targeted hormone therapy.
Radiation Oncologist
A specialist physician who uses targeted ionizing radiation therapy to shrink or destroy cancer cells and tumours.
Surgical Oncologist
A surgeon who specializes in the surgical resection and physical removal of cancerous tumours and adjacent affected tissues.
Neoplasia
The biological process involving abnormal and uncontrolled cellular proliferation and growth, which may lead to the formation of a neoplasm.
Neoplasm
An abnormal mass of cells or tissue resulting from the process of neoplasia; commonly referred to as a tumour.
Benign Tumour
A non-cancerous neoplasm composed of well-differentiated cells that are typically slow-growing, encapsulated, localized, non-invasive, and incapable of metastasizing.
Malignant Tumour
A cancerous neoplasm composed of poorly differentiated or undifferentiated cells that proliferate rapidly, are rarely encapsulated, invade local tissues, and metastasize via blood or lymph vessels.
Solid Cancers
Cancers that develop as discrete cellular masses or tumours within organ systems, such as breast, lung, and colorectal cancers.
Haematological Cancers
Liquid cancers that involve blood-forming tissues, bone marrow, or the lymphatic system rather than discrete solid masses, such as leukemias, lymphomas, and multiple myeloma.
Adenocarcinomas
Malignant cancers originating in epithelial tissues that line organs and cavities, such as those found in breast, prostate, lung, and colon cancers.
Sarcomas
Malignant tumours that develop from mesenchymal or connective tissues, including bone (osteosarcoma) and adipose tissue (liposarcoma).
Leukemias
Cancers originating in blood-forming tissue within the bone marrow, such as acute lymphoblastic leukemia (ALL), impairing healthy blood cell production.
Lymphomas
Cancers that originate in the cells of the lymphatic system, categorized broadly into Hodgkin lymphoma and non-Hodgkin lymphoma.
Myelomas
Cancers that arise from malignant plasma cells in the bone marrow, most commonly presenting as multiple myeloma.
Central Nervous System (CNS) Tumours
Malignancies that originate in nervous tissue, such as glioblastomas and astrocytomas.
Primary Cancer
The original anatomical site where cancer cells first begin to proliferate.
New Primary Cancer
A distinct, completely new cancer that originates in a different anatomical site, entirely unrelated to a previously diagnosed cancer.
Secondary Cancer (Metastatic Cancer)
Cancer that has disseminated from its original primary site to establish new tumour growth in other tissues or organs of the body.
Local Spread
The direct growth and infiltration of cancer cells into immediately adjacent tissues or anatomical structures.
Regional Spread
The dissemination and growth of cancer cells into nearby regional lymph nodes.
Distant Spread (Metastasis)
The transportation of malignant cancer cells via the bloodstream or lymphatic pathways to colonize distant organs.
Remission
A reduction in or complete disappearance of the signs and symptoms of cancer, categorized clinically as partial remission or complete remission.
Disease-Free
A sustained period of complete remission following cancer treatment (typically <5years), indicating treatment success without guaranteeing a permanent cure.
Cured (in Oncology)
A statistical and clinical milestone achieved when a person has been disease-free for an extended duration (typically >5years) such that their recurrence risk equals that of the general population.
Cachexia
A systemic metabolic syndrome caused by advanced malignancies characterized by progressive, involuntary weight loss, skeletal muscle wasting, and profound fatigue.
Paraneoplastic Syndromes
Systemic hormonal, biochemical, or electrolyte imbalances triggered by bioactive molecules or hormones inappropriately secreted by tumour cells.
B Symptoms
A triad of systemic symptoms characteristic of lymphomas consisting of unexplained fever, drenching night sweats, and significant involuntary weight loss.

Phases of the Cancer Journey
A continuum of clinical care models through which a person with cancer progresses, comprising prevention, screening, diagnosis, treatment, and either recovery/survivorship or end-of-life care.
Accelerated Biological Ageing
A physiological consequence of oncology treatments that exposes cancer survivors to the premature onset of chronic conditions such as cardiovascular disease, frailty, type 2 diabetes, and osteoporosis.
Prehabilitation
An exercise and lifestyle intervention implemented between cancer diagnosis and the commencement of acute medical treatment to optimize physical function and treatment tolerance.
Physical Activity and Cancer Control (PACC) Framework
A clinical model providing a structured blueprint for applying targeted exercise interventions across every phase of cancer care, from prevention to palliative management.
Palliative Care (in Cancer Exercise)
The application of clinical exercise prescription in advanced, incurable disease to manage symptoms, optimize physical functioning, and maximize quality of life.
Medicare
Australia's public universal healthcare system that covers or subsidizes medical services and treatment in public hospitals for Australian citizens and permanent residents.
Private Health Insurance (PHI)
Optional health coverage in Australia designed to complement Medicare by paying for private hospital care and non-hospital ancillary healthcare services.
Hospital Cover
A private health insurance policy type that helps pay for hospital accommodation, doctor or specialist fees, and theatre charges when treated as a private patient.
Extras Cover
A private health insurance policy that covers day-to-day, out-of-hospital medical and allied health treatments that are generally not funded by Medicare.
Ancillary Provider
A registered healthcare professional, such as an Accredited Exercise Physiologist (AEP), who delivers non-hospital clinical services claimable under private health insurance Extras policies.
Private Health Insurance Act 2007
The Australian legislative statute providing the legal and regulatory framework governing private health insurance funds, products, and general treatment definitions.
General Treatment
Healthcare under the Private Health Insurance Act 2007 intended to prevent or manage a disease, condition, or injury without involving hospital admission, explicitly excluding sport, recreation, or general fitness.
ESSA General Treatment Criteria
The four benchmark criteria established by Exercise & Sports Science Australia for private health claims: interventions must be specific, measurable, clinically justified, and targeted to modifiable risk factors.
Chronic Disease (PHI Definition)
Under private health insurance legislation, a condition that has been, or is likely to be, present for at least 6months, accompanied by physical inactivity or biomedical risk factors.
Chronic Disease Management (CDM) Referral (Insurer)
A private health insurer referral program aimed either at reducing complications in diagnosed chronic disease or delaying the onset of disease in individuals with multiple identified risk factors.
Onward Referral to AES
A clinical pathway allowing an Accredited Exercise Physiologist to refer a client with an existing medical condition to an Accredited Exercise Scientist for personal training funded under select Extras policies.
Item 102
The private health insurance billing item code for an initial, once-only per course of treatment individual exercise physiology consultation lasting longer than 45minutes.
Item 202
The private health insurance billing item code for a standard individual exercise physiology consultation lasting 30–60minutes.
Item 302
The private health insurance billing item code for an extended individual exercise physiology consultation lasting longer than 60minutes.
Item 502
The private health insurance billing item code for a 60minute group exercise physiology consultation involving between 2 and 8 participants.
HICAPS
An electronic health claims and payment processing platform that enables ancillary providers to process private health insurance benefits on the spot, requiring clients to pay only the gap.